Trastuzumab: A Viewpoint by Mark Pegram

Author： Pegram M.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.12, Iss.2, 1999-08, pp. : 136-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Trastuzumab

By Perry C.M.   Wiseman L.R.  

BioDrugs, Vol. 12, Iss. 2, 1999-08 ,pp. : 129-135

Adis International

Access to resources Recommend Favorite

Clobetasol Propionate Foam, 0.05%: A Viewpoint by Mark Lebwohl and Amy Krupnick

By Lebwohl M.  

American Journal of Clinical Dermatology, Vol. 2, Iss. 2, 2001-02 ,pp. : 93-93

Adis International

Access to resources Recommend Favorite

Etanercept: A Viewpoint by Muhammad A. Khan

By Khan M.A.  

BioDrugs, Vol. 18, Iss. 3, 2004-01 ,pp. : 206-206

Adis International

Access to resources Recommend Favorite

Alefacept: A Viewpoint by Alice Gottlieb

By Gottlieb A.  

American Journal of Clinical Dermatology, Vol. 4, Iss. 4, 2003-01 ,pp. : 287-287

Adis International

Access to resources Recommend Favorite

Imiquimod: A Viewpoint by John Geisse

By Geisse John  

American Journal of Clinical Dermatology, Vol. 6, Iss. 3, 2005-01 ,pp. : 201-201

Adis International

Access to resources Recommend Favorite